Prim, S.A. (PRM.MC) has a MoatMap StockRank of 100/100 based on Quality (76/100), Value (72/100), and Momentum (59/100) factor scores. The current signal is STRONG BUY. Prim, S.A., a Spanish healthcare provider, is a strong beneficiary of the 'Resilient Consumer Staples (Ex-US)' macro theme. As an essential service in a developed ex-US market, it offers stable, compounding growth with pricing power, which the market often overlooks in favor of high-growth tech, leading to attractive valuations. The quant scores suggest a quality business trading at a reasonable price.
| Price | $15.02 |
| Market Cap | $261M |
| P/E (TTM) | 13.57 |
| P/E (Forward) | 10.21 |
| Price/Book | 1.64 |
| Return on Equity | 12.5% |
| Return on Invested Capital | 15.0% |
| Debt/Equity | 11.24 |
| Gross Margin | 50.0% |
| Operating Margin | 7.1% |
| Revenue Growth | 9.9% |
| Dividend Yield | 4.5% |
| Free Cash Flow | $21M |
Prim, S.A. operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (Spain).